Skip to content

Interleukin-1 Alpha, Cerebrospinal Fluid — Mass Concentration

Published: August 9, 2026Updated: August 16, 2026

Measures the amount of interleukin-1 alpha, an inflammatory signaling protein, in cerebrospinal fluid. This specialized test may help evaluate inflammation within the central nervous system.

Quick summary

["An elevated CSF IL-1 alpha level may indicate inflammation in or around the central nervous system, but it does not identify the cause by itself."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
70075-7
Short code
Il1Alpha CSF-mCnc
Synonyms
Il1Alpha CSF-mCnc
Category
liver
Sample
csf
Container
Sterile tube
Units
N/A
Ref low
44
Ref high
147
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
84075
SNOMED
27550007
Specimen volume
1-2 mL
Stability
Immediate analysis required, Refrigerated: 1h
Hemolysis max
200
TAT
4–24 hours
Order
routine

What is this test?

Interleukin-1 alpha, or IL-1 alpha, is a protein involved in the body's inflammatory response. This test measures its mass concentration in cerebrospinal fluid, the fluid surrounding the brain and spinal cord.

Why might I need this test?

This test may be considered when symptoms suggest inflammation or infection involving the brain or spinal cord, particularly when the cause is unclear. It is generally a specialized test rather than part of routine cerebrospinal fluid testing.

How is the test performed?

Cerebrospinal fluid is usually collected through a lumbar puncture, in which a needle is inserted into the lower back to remove fluid. The laboratory uses a validated assay to determine the amount of IL-1 alpha present.

How do I prepare for the test?

Preparation depends on the instructions provided by the clinician performing the lumbar puncture. Tell the healthcare team if you have bleeding disorders, take blood-thinning medicines, or have a back condition, and follow their instructions about food, fluids, and medicines.

Reference range

Adult: 44-147 U/LN/A

Specimen: csf

No special preparation required. Avoid fatty meals before the test if possible.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

A higher-than-expected IL-1 alpha concentration may be associated with inflammatory or infectious conditions affecting the central nervous system. However, IL-1 alpha is not specific to one disease, and an abnormal result must be interpreted with symptoms, other cerebrospinal fluid findings, and other laboratory tests.

Short name

CSF IL-1 Alpha

Frequently asked questions

Is this the same as a routine lumbar puncture test?
No. The sample may be collected during a lumbar puncture, but IL-1 alpha measurement is a specialized add-on test and is not usually part of the standard panel.
Does an elevated result diagnose a specific condition?
No. Elevated IL-1 alpha can occur with several inflammatory or infectious conditions and must be interpreted alongside the overall clinical evaluation.
Is this test available for all patients?
No. Its use depends on the clinical situation, and the test may need to be ordered by a specialist or sent to a reference laboratory.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy